Murthy Mala's Form 4 filing
Teladoc Health, Inc. (TDOC) · filed Mar 5, 2024
- Accession no.
- 0001477449-24-000039
- Filed
- Mar 5, 2024
- Trade date
- Mar 1-4, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 8 non-derivative transactions and 8 derivative transactions. Open-market sales total $434.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Murthy MalaCIK 0001780955 | Officer (CHIEF FINANCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +10,565 | –F1 | – | 59,880 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +945 | –F1 | – | 60,825 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +1,878 | –F1 | – | 62,703 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +3,369 | –F2 | – | 66,072 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +2,044 | –F2 | – | 68,116 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +31,002 | –F2 | – | 99,118 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +2,486 | –F2 | – | 101,604 | Direct | |
| Mar 4, 2024 | Common Stock | SSaleDisposed | −29,888 | $14.52 | −$433,973.76 | 71,716 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Common Stock | AGrant or awardAcquired | +31,696 | $0.00 | $0 | 31,696 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −10,565 | $0.00 | $0 | 21,131 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −945 | $0.00 | $0 | 0 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −1,878 | $0.00 | $0 | 0 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −3,369 | $0.00 | $0 | 13,476 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −2,044 | $0.00 | $0 | 10,220 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −31,002 | $0.00 | $0 | 62,004 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −2,486 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
Referenced by the price of 3 transactions in Table I.
- F2
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Referenced by the price of 4 transactions in Table I.